Home›People›Peter Maag
PM

Peter Maag

Executive Chair at CareDx. Also an executive officer and director at Kyverna Therapeutics.

ExecutiveDirectorPublic company
Updated Nov 9, 2026·Latest SEC filing Jul 10, 2025·Suggest an edit

About Peter Maag

Peter Maag is an executive chair at CareDx.

Form D filings name Peter Maag as an executive officer and director at Kyverna Therapeutics.

Peter Maag reports to the SEC as a director or officer of 3 public companies, including Kyverna Therapeutics (KYTX) and Miromatrix Medical (MIRO).

Peter Maag first appears on SEC filings in 2014.

Experience

This experience comes from SEC filings. The years are when the filings name Peter Maag in the role, so the role may have started earlier or lasted longer.

CareDx, Inc.
Executive Chair
2014 – 2025 · Public company (CDNA)
Kyverna Therapeutics, Inc.
Chief Executive Officer and director
2023 – 2024 · Public company (KYTX)
Miromatrix Medical Inc.
Director
2021 – 2023 · Public company (MIRO)

Key Colleagues at Startups

The people Peter Maag works with at each company, as listed on that company's latest Form D.

Kyverna Therapeutics, Inc. · Form D, Nov 7, 2023
BK
Brian Kotzin
Director
IC
Ian Clark
Director
RJ
Ryan Jones
Chief Financial Officer
KW
Karen Walker
Executive officer
JC
James Chung
Executive officer
DS
BS
FC
Fred Cohen
Director
SL
Steve Liapis
Director
DB
Dominic Borie
Executive officer

Sources

  1. SECKyverna Therapeutics, Inc. Form D, filed Nov 7, 2023
  2. SECForms 3, 4 and 5 filed by Peter Maag (SEC filer 1613855)